Article Versions Notes

Safi S, Yamauchi Y, Hoffmann H, Weichert W, Jost PJ, Winter H, Muley T, Beckhove P. Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer. Cancers. 2020; 12(12):3496. https://doi.org/10.3390/cancers12123496

Safi, Seyer, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp J. Jost, Hauke Winter, Thomas Muley, and Philipp Beckhove. 2020. "Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer" Cancers 12, no. 12: 3496. https://doi.org/10.3390/cancers12123496

Safi, S., Yamauchi, Y., Hoffmann, H., Weichert, W., Jost, P. J., Winter, H., Muley, T., & Beckhove, P. (2020). Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer. Cancers, 12(12), 3496. https://doi.org/10.3390/cancers12123496